Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for T-Cell Prolymphocytic Leukemia after Alemtuzumab Induction Therapy: A Case Report

T-cell prolymphocytic leukemia (T-PLL) is a rare aggressive disease with a poor prognosis. Allogeneic stem cell transplantation (allo-SCT) followed by alemtuzumab administration is the most promising treatment for T-PLL but is associated with a high risk of infections as alemtuzumab strongly suppres...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Naoki Okada, Ryusuke Yamamoto, Hayato Maruoka, Mayuko Himeno, Nobuhiro Hiramoto, Takayuki Ishikawa
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Karger Publishers 2023-08-01
Schriftenreihe:	Case Reports in Oncology
Schlagworte:	haploidentical stem cell transplantation post-transplant cyclophosphamide t-cell prolymphocytic leukemia alemtuzumab
Online-Zugang:	https://beta.karger.com/Article/FullText/531471
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!